Tamen Jadad-Garcia,Alejandro R. Jadad
Abstract:Introduction: As digital health evolves, identifying factors that drive success is crucial. This study examines how reimbursement billing codes affect the long-term financial performance of digital health companies on U.S. stock markets, addressing the question: What separates the winners from the rest?
Methods: We analyzed digital health companies that went public on U.S. stock exchanges between 2010 and 2021, offering products or services aimed at improving personal health or disease management within the U.S. market. A search using Google and existing IPO lists identified eligible companies. They were categorized based on the presence or absence of billing codes at the time of their initial public offering (IPO). Key performance indicators, including Compound Annual Growth Rate (CAGR), relative performance to benchmark indices, and market capitalization change, were compared using Mann-Whitney U and Fisher's Exact tests.
Results: Of the 33 companies analyzed, 15 (45.5%) had billing codes at IPO. The median IPO price was $17.00, with no significant difference between groups. Those with billing codes were 25.5 times more likely to achieve a positive CAGR. Their median market capitalization increased 56.3%, compared to a median decline of 80.1% for those without billing codes. All five top performers, in terms of CAGR, had billing codes at IPO, whereas nine of the ten worst performers lacked them. Companies without billing codes were 16 times more likely to experience a drop in market capitalization by the study's end.
Conclusion: Founders, investors, developers and analysts may have overestimated consumers' willingness to pay out-of-pocket or underestimated reimbursement complexities. As the sector evolves, especially with AI-driven solutions, stakeholders should prioritize billing codes to ensure sustainable growth, financial stability, and maximized investor returns.
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve
This paper attempts to explore whether the presence of billing codes at the time of a digital health company's initial public offering (IPO) has an impact on its long-term financial performance. Specifically, the authors aim to answer the following key question:
**"What factors distinguish the winners from the losers in the competitive landscape of digital health?"**
### Research Background
As digital health technology continues to evolve, investors and industry leaders are striving to identify the factors driving success in this rapidly growing field. This paper examines the performance of digital health companies listed on U.S. stock exchanges from 2010 to 2021, particularly whether these companies had billing codes at the time of their IPO, to explore this issue.
### Main Research Questions
- **What impact does the presence or absence of billing codes have on the stock market performance of digital health companies?**
- **How do companies with billing codes perform financially in the long term after their IPO?**
- **How do companies without billing codes perform after their IPO?**
### Research Methods
1. **Sample Selection**:
- Selected digital health companies listed on U.S. stock exchanges from 2010 to 2021.
- These companies offer products or services aimed at improving personal health or disease management and have operations in the U.S. market.
2. **Data Collection**:
- Collected relevant information for each IPO company, including company name, stock ticker, headquarters location, stock exchange, CEO background, digital health sector, IPO date, IPO price, opening price, first-day closing price, historical low price, etc.
- Obtained stock value and composite index data from public databases such as Yahoo Finance and StockAnalysis.
- Determined the presence of billing codes through company websites, materials submitted to the Securities and Exchange Commission, and news reports.
3. **Data Analysis**:
- Calculated multiple performance indicators, including compound annual growth rate (CAGR), performance relative to benchmark indices, changes in market capitalization, etc.
- Used Mann-Whitney U test and Fisher's exact test to compare the performance of companies with and without billing codes across various indicators.
### Research Results
- **Overall Characteristics**:
- Among the 33 eligible companies, 15 (45.5%) had billing codes at the time of their IPO, while 18 (54.5%) did not.
- There was no significant difference in IPO prices between companies with and without billing codes.
- **Short-term Performance**:
- On the first day of trading, 84.8% of companies achieved positive returns, but there was no significant difference in first-day performance between companies with and without billing codes.
- **Long-term Performance**:
- Companies with billing codes significantly outperformed those without in terms of CAGR, performance relative to benchmark indices, and changes in market capitalization.
- Among companies with billing codes, 9 (81.8%) had stock prices higher than the first-day closing price as of June 30, 2024, compared to only 1 company (11.1%) without billing codes.
- Among companies with billing codes, 90% achieved positive CAGR, compared to only 1 company (5.6%) without billing codes.
- Among companies with billing codes, 69.2% had market capitalization exceeding $1 billion as of June 30, 2024, compared to only 1 company (5.6%) without billing codes.
### Conclusion
- **Key Findings**:
- Billing codes have a significant impact on the long-term success of digital health companies. Companies with billing codes perform significantly better financially in the long term after their IPO compared to those without billing codes.
- Companies with billing codes are more likely to achieve positive CAGR, have stock prices higher than the first-day closing price, and experience faster growth in market capitalization.
- Companies without billing codes are more likely to experience significant declines in market capitalization.
- **Practical Implications**:
- For founders, executives, and developers, optimizing products and services to obtain billing codes is crucial.
- Investors should consider billing codes as a key criterion when evaluating potential investment opportunities.